Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation.
暂无分享,去创建一个
P. Valenti | F. Berlutti | R. Sessa | M. Di Pietro | S. Filardo | A. Bressan | L. Rosa | A. Cutone | A. Frioni | R. Paesano
[1] J. Hegemann,et al. The Chlamydia trachomatis Ctad1 invasin exploits the human integrin β1 receptor for host cell entry , 2016, Cellular microbiology.
[2] Marleen Temmerman,et al. Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.
[3] K. Workowski,et al. Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[4] Virginia Apgar. A Proposal for a New Method of Evaluation of the Newborn Infant , 2015, Anesthesia and analgesia.
[5] R. Ragno,et al. Effects of Mentha suaveolens Essential Oil on Chlamydia trachomatis , 2015, BioMed research international.
[6] S. Kohlhoff,et al. Treatment of chlamydial infections: 2014 update , 2015, Expert opinion on pharmacotherapy.
[7] E. McLaughlin,et al. The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged Sword , 2014, Front. Immunol..
[8] G. Schiavoni,et al. Effects of vaginal lactobacilli in Chlamydia trachomatis infection. , 2014, International journal of medical microbiology : IJMM.
[9] P. Valenti,et al. Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases , 2014, BioMetals.
[10] R. Bastidas,et al. Chlamydial intracellular survival strategies. , 2013, Cold Spring Harbor perspectives in medicine.
[11] R. Sessa,et al. New Insights into Chlamydiae Persistence: An Energy Metabolism Strategy? , 2013, International journal of immunopathology and pharmacology.
[12] P. Valenti,et al. Bovine lactoferrin in preventing preterm delivery associated with sterile inflammation. , 2012, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[13] Bingyun Li,et al. Nanomedicine as an emerging approach against intracellular pathogens , 2011, International journal of nanomedicine.
[14] F. Pantanella,et al. Lactoferrin Decreases Inflammatory Response by Cystic Fibrosis Bronchial Cells Invaded with Burkholderia Cenocepacia Iron-Modulated Biofilm , 2011, International journal of immunopathology and pharmacology.
[15] Chengyu Jiang,et al. Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans , 2011, PloS one.
[16] P. Valenti,et al. Bovine Lactoferrin Counteracts Toll-Like Receptor Mediated Activation Signals in Antigen Presenting Cells , 2011, PloS one.
[17] M. O’Sullivan,et al. Public health policies and management strategies for genital Chlamydia trachomatis infection , 2011, Risk management and healthcare policy.
[18] R. Carabeo,et al. An Optimal Method of Iron Starvation of the Obligate Intracellular Pathogen, Chlamydia Trachomatis , 2011, Front. Microbio..
[19] P. Wyrick. Chlamydia trachomatis persistence in vitro: an overview. , 2010, The Journal of infectious diseases.
[20] A. Schryvers,et al. The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus. , 2008, Biochemistry.
[21] M. Ammendolia,et al. Bovine Lactoferrin Inhibits the Efficiency of Invasion of Respiratory A549 Cells of Different Iron-Regulated Morphological Forms of Pseudomonas Aeruginosa and Burkholderia Cenocepacia , 2008, International journal of immunopathology and pharmacology.
[22] G. Donnarumma,et al. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[23] P. Valenti,et al. Lactoferrin: an important host defence against microbial and viral attack. , 2005, Cellular and molecular life sciences : CMLS.
[24] B. Lönnerdal,et al. Cellular internalization of lactoferrin in intestinal epithelial cells , 2004, Biometals.
[25] F. Superti,et al. Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. , 2004, Journal of medical microbiology.
[26] L. G. Giugliano,et al. In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins , 2004, BMC Microbiology.
[27] P. Timms,et al. Chlamydial Persistence: beyond the Biphasic Paradigm , 2004, Infection and Immunity.
[28] Gale R. Burstein,et al. Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.
[29] G. Zhong,et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] Christina H. Park,et al. Antimicrobial components of vaginal fluid. , 2002, American journal of obstetrics and gynecology.
[31] T. Meyer,et al. Low iron availability modulates the course of Chlamydia pneumoniae infection , 2001, Cellular microbiology.
[32] J. Raulston. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins , 1997, Infection and immunity.
[33] D. Monroe,et al. Characterization of the glycosaminoglycan-binding region of lactoferrin. , 1995, Archives of biochemistry and biophysics.
[34] A. Alfsen,et al. Influence of lactoferrin on the entry process of Escherichia coli HB101(pRI203) in HeLa cells , 1993, Medical Microbiology and Immunology.
[35] E. Schonne,et al. LACTOFERRIN, AN IRON-BINBING PROTEIN NI NEUTROPHILIC LEUKOCYTES , 1969, The Journal of experimental medicine.
[36] P. Valenti,et al. Anti-invasive activity of bovine lactoferrin towards group A streptococci. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.